Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #11612
Ace Report Cover Spine

Topical TXA superior to placebo in reducing blood loss after instrumented posterior spinal fusion

Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

A Randomized Controlled Trial of Topical Application of Tranexamic Acid in Patients with Thoracolumbar Spine Trauma Undergoing Long-Segment Instrumented Posterior Spinal Fusion

Asian Spine J. 2019 Feb;13(1):146-154.

Contributing Authors: W Sudprasert T Tanaviriyachai K Choovongkomol S Jongkittanakul U Piyapromdee

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


60 patients between the ages of 18-70 with thoracolumbar spinal injuries and scheduled for long segment instrumented posterior spinal fusion surgeries with local autologous bone grafts were randomized to receive topical tranexamic acid (TXA) or a placebo solution for the control of blood loss and need for transfusion. The primary outcome of interest was post-operative packed red blood cell transfu...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.